AJTMH ASTMH MEMBERSHIP INFORMATION: astmh@astmh.org
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am. J. Trop. Med. Hyg., 76(3), 2007, pp. 579-584
Copyright © 2007 by The American Society of Tropical Medicine and Hygiene

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by TONUI, W. K.
Right arrow Articles by TITUS, R. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by TONUI, W. K.
Right arrow Articles by TITUS, R. G.
Related Collections
Right arrow Vaccine
Right arrow Leishmaniasis

CROSS-PROTECTION AGAINST LEISHMANIA DONOVANI BUT NOT L. BRAZILIENSIS CAUSED BY VACCINATION WITH L. MAJOR SOLUBLE PROMASTIGOTE EXOGENOUS ANTIGENS IN BALB/C MICE

WILLY K. TONUI AND RICHARD G. TITUS*
Centre for Biotechnology Research and Development, Kenya Medical Research Institute, Nairobi, Kenya; Department of Microbiology Immunology and Pathology, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins Colorado

Vaccinating with soluble Leishmania major promastigote exogenous antigens (LmSEAgs) protects mice against challenge with L. major. To explore the potential of LmSEAgs to cross-protect against infection with other species of Leishmania, BALB/c mice were immunized with LmSEAgs prior to challenge with either L. donovani or L. braziliensis promastigotes. Such mice were protected against L. donovani but not L. braziliensis infection. Leishmania braziliensis–infected mice developed lesions that were not significantly different from those of controls and that contained 13-fold more parasites. In contrast, immunized mice infected with L. donovani were protected as illustrated by low splenic parasite loads (as much as 4,913-fold fewer parasites). This protection corresponded to significant increases in gamma interferon and low production of interleukin-4 (IL-4) IL-4 or IL-10, which suggested an enhanced type 1 response.

Received July 18, 2006. Accepted for publication November 27, 2006.

Acknowledgments: We thank Sheryl Carter and Jeanette V. Bishop for technical assistance, and Lisa P. Hochberg, Jeffrey R. Ryan, and Samuel K. Martin for help in many facets of this project.

Financial support: This study was supported by The Medical Research and Materiel Command, Military Infectious Diseases Research Program, Contract number DAMD17-01-P-0237 and National Institutes of Health AI 027511, AI029955, and AI 065784.

* Address correspondence to Richard G. Titus, Department of Microbiology, Immunology and Pathology, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO 80523-1619. E-mail: rtitus{at}colostate.edu

Authors’ addresses: Willy K. Tonui, Centre for Biotechnology Research and Development, Kenya Medical Research Institute, PO Box 54840, Nairobi 00200, Kenya, Telephone: 254-020-2722541/4, E-mail: wtonui{at}kemri.org. Richard G. Titus, Department of Microbiology, Immunology and Pathology, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO 80523-1619, Telephone: 970-491-4964, Fax: 970-491 0603, E-mail: rtitus{at}colostate.edu.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the American Society of Tropical Medicine and Hygiene.